Today's Portrait Highlights

Innovation Skåne AB: Increased efficiency and quality in the healthcare through innovation

Innovation Skåne AB supports entrepreneurs in the development of fast-growing companies and contributes to increased efficiency and quality in the healthcare through innovation. Our HealthTech Arena is a test bed and meeting place where Innovative HealthTech companies have the opportunity to test and validate their e-health products and services against real needs in the healthcare sector, from product idea and onwards. Services include idea testing, IT testing and usability, and, moreover, Innovation Skåne provides access to clinical trials through its sister organisation.

Lanthio Pharma

Lanthio Pharma is focused on discovering and developing lantipeptide drugs for serious diseases. We are working on lanthipeptides as new treatment for fibrosis, stroke, heart failure and multiple sclerosis. To discover and produce drug candidates, we apply our proprietary LanthioPep technology. This technology uses modified Lactococcus bacteria to make constrained peptides, called lanthipeptides. Our lanthipeptides are more disease target selective and more stable in plasma compared to linear wild-type peptides, making them more suitable as drug candidates.

Biomedro Biotech GmbH

BIOMEDRO GmbH is committed to basic medical research, the development of diagnostic test systems, and the carrying out of clinical studies investigating innovative treatment and diagnostic strategies in rheumatic autoimmune diseases. The medical research has a predominant focus on biomarker discovery using sophisticated proteomics approaches such as two-dimensional gel electrophoresis. BIOMEDRO DIAGNOSTICS develops ELISA tests using individual, highly purified recombinant antigens – resulting in hits that are very specific.